/

Empresas

Ju

No verificado

Juniper Biosciences

Sobre qué escribimos

Anuncios brevesBiotecnologíaFinanzasMedicina Salud Bienestar

5 Comunicados de prensa

Ver todos los comunicados de prensa

15/09/2026

Biotecnología

Anuncios breves

Juniper Biosciences Unveils JBS-002 and JBS-004, Advancing Two Late-Stage Diagnostic Programs to Registration Batch Manufacturing in the Fourth Quarter of 2026

Fuente

Juniper Biosciences

Editor

1.00

0

01/09/2026

Biotecnología

Medicina Salud Bienestar

Juniper’s JBS-003 (F-MISO) Program Receives FDA Breakthrough Therapy Designation, Advancing a First-in-Class Hypoxia Tracer Enabling Radiation De-escalation in HPV-Positive Head and Neck Cancer

Fuente

Juniper Biosciences

Editor

1.00

0

18/05/2026

Biotecnología

Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board

Fuente

Juniper Biosciences

Editor

1.00

0

28/04/2026

Biotecnología

Juniper Biosciences Announces Strategic Collaboration with leading global cancer center on F-MISO (JBS-003): A First-in-Class Precision Diagnostic Poised to Revolutionize Head and Neck Cancer Treatment

Fuente

Juniper Biosciences

Editor

1.00

0

01/12/2025

Biotecnología

Finanzas

Medicina Salud Bienestar

Juniper Biosciences Raises Oversubscribed and Upsized $40 Million Seed Financing to Fund Development of Its Innovative Pipeline

Fuente

Juniper Biosciences

Editor

1.00

0

Seguidores

0

Compatibilidad

0